Evidence map›Paper›PMID 37880709›Full record

ArticleJournal of cardiothoracic surgery2023

Zone 2/3 lesion and emergency repair as potential mortality predictors of TEVAR for thoracic aortic pseudoaneurysm.

Hui Wang, Chang Shu, Tun Wang, Hao He, Xin Li, Quanming Li, Yuan Peng, Lunchang Wang, Likun Sun

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of cardiothoracic surgery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Hui Wang *Department of Vascular Surgery, The Second Xiangya Hospital of Central South University, Changsha, 410011, Hunan, China.
Chang Shu *Department of Vascular Surgery, The Second Xiangya Hospital of Central South University, Changsha, 410011, Hunan, China. shuchang@csu.edu.cn.
Tun WangDepartment of Vascular Surgery, The Second Xiangya Hospital of Central South University, Changsha, 410011, Hunan, China.
Hao HeDepartment of Vascular Surgery, The Second Xiangya Hospital of Central South University, Changsha, 410011, Hunan, China.
Xin LiDepartment of Vascular Surgery, The Second Xiangya Hospital of Central South University, Changsha, 410011, Hunan, China.
Quanming LiDepartment of Vascular Surgery, The Second Xiangya Hospital of Central South University, Changsha, 410011, Hunan, China.
Yuan PengDepartment of Vascular Surgery, The Second Xiangya Hospital of Central South University, Changsha, 410011, Hunan, China.
Lunchang WangDepartment of Vascular Surgery, The Second Xiangya Hospital of Central South University, Changsha, 410011, Hunan, China.
Likun SunDepartment of Vascular Surgery, The Second Xiangya Hospital of Central South University, Changsha, 410011, Hunan, China.
Second Xiangya Hospital of Central South University · CNCentral South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThoracic aortic pseudoaneurysm (TAP) is an uncommon but life-threatening condition. The present study aimed to investigate the early and midterm clinical outcome of TAP patients following TEVAR and identify potential mortality predictors.

methodsWe retrospectively reviewed a series of 37 eligible patients with TAP admitted to our hospital from July 2010 to July 2020. We explored their baseline, perioperative and follow-up data. Fisher exact test and Kaplan-Meier method were applied for comparing difference between groups.

resultsThere were 29 men and 12 women, with the mean age as 59.5 ± 13.0 years (range 30-82). The mean follow-up period was 30.7 ± 28.3 months (range 1-89). For early outcome (≤ 30 days), mortality happened in 3 (8.1%) zone 3 TAP patients versus 0 in zone 4 (p = 0.028); postoperative acute arterial embolism of lower extremity and type II endoleak respectively occurred in 1(2.7%) case. For midterm outcome, survival at 3 months, 1 year and 5 years was 88.8%, 75.9% and 68.3%, which showed significant difference between zone 2/3 versus zone 4 group (56.3% vs. 72.9%, p = 0.013) and emergent versus elective TEVAR group (0.0% versus 80.1%, p = 0.049). Previous stent grafting or esophageal foreign body with Aortoesophageal fistula (AEF), and systemic vasculitis, as etiologies, resulted in encouraging immediate outcome but worse midterm prognosis.

conclusionTAP lesions at zone 2/3 and emergent TEVAR predict worse midterm outcomes compared to zone 4 lesions and elective TEVAR. The outcomes are also mainly restricted by the etiology of the TAP.

Indexed as

Aneurysm, FalseAortic Aneurysm, ThoracicBlood Vessel Prosthesis ImplantationEndovascular ProceduresAdultAgedAged, 80 and overAorta, ThoracicBlood Vessel ProsthesisEndovascular Aneurysm RepairFemaleHumansMaleMiddle AgedRetrospective StudiesStentsAortic pseudoaneurysmAortoesophageal fistulaThoracic endovascular aortic repair

Identifiers

PMID37880709
PMCPMC10599020
OpenAlexW4387939846

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.